Xtandi (enzalutamide)

pCPA File Number: 21112
Negotiation Status:
Concluded with an LOI
Indication(s):
non-metastatic castrate resistant prostate cancer
Sponsor/Manufacturer:
Astellas Pharma Inc.
CADTH Project Number:
pCODR 10149
pCPA Engagement Letter Issued:
Negotiation Process Concluded: